Clinical Trial Search

Primary: Differences Between Plain and Spiced Vegetables Intake — 134.1; 212.5; 204.8; 178.1 gram — p=0.001

Primary: Vegetable Intake Carotenoid Scores at 3 Months — 227.11; 269.98 units on a scale — p=0.001

Primary: Change of Total Urine SFN (Sulforaphane) Metabolites — 4.75; -0.02 micromolar (µM) concentrations of urina

Primary: Change From Baseline in Alveolar Macrophage Expression of Nrf2 and Associated Genes at 4 Weeks — 0.80; 1.03; 0.94; 0.90 fold change — p=0.45

Primary: Effect of Treatment on Levels of Air Toxics Mercapturic Acids Over Intervention Period — 1.700; 1.065 pmol/mg creatinine

Primary: Sulforaphane Bioavailability Measured in Sequential 12-Hour Urine Samples — 24.8; 11.0; 4.3 micromoles/24 hours — p=<0.001

Primary: Absolute Change in Mean Proliferative Rate Measured by Ki67% — -1.15; 4 percentage of Ki67 — p=0.32

Primary: Change in Urinary Excretion of the Mercapturic Acid of Benzene Following 4 Tablets Per Day of Avmacol — 1.16 data presented as ratio; no unit

Primary: Gut Leak — 2.60; 3.23; 26.75; 28.57 ng/mL

Primary: Change in Isothiocyanate in Urine Samples as Assessed at Baseline and After Completion of Study Therapy — 1.00; -0.05 µM/mM creatinine

Primary: Mean Level of Diindolylmethane in Prostate Tissue After Treatment — 14.2 ng/g

Primary: C-reactive Protein — 160.7; 173.4; 211.4 ng/mL

Primary: Exhaled Nitric Oxide Concentrations — 22; 19 ppb

Primary: Change From Screening/Baseline in Social Responsiveness Scale (SRS) at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks — -7.79; -14.76; -1.38; -14.48 units on a scale

Primary: Change in Ohio Autism Clinical Impressions Scale - Improvement (OACIS-I) Average Score From Baseline — 0.28; 0.28; 0.28; 0.33 score on a scale

Primary: Gene Expression of Phase II Enzymes — -0.36; 0.26; 0.15; -0.59 -fold change in expression

Primary: Difference Between Interventions in Vegetable Intake — 32; 57; 31; 50 grams — p=0.1260

Primary: Midazolam Clearance (Pharmacokinetic Measure of Cytochrome P450 3A4 Activity) — 604; 552; 541; 156 ng*min/ml

Primary: Social Responsiveness Scale-2 (SRS-2) Total Score at Baseline — 75.6; 72.6 T-score — p=0.331

Primary: The Primary Outcome is the Change in Bronchodilation and Bronchoprotection After Broccoli Sprout Extract — 10.3; 26.7 index

Primary: Total Nasal Symptom Score (TNSS) Change From Baseline to 3 Weeks of Randomly Assigned Treatment — -.5277; -.5484; -.8359; -.181 score on a scale

Primary: Adherence to Treatment — 4; 1 Participants

Primary: Effect of Short-term (1-week) Plant- and Animal-based Eating Patterns on Hydrogen Sulfide Production — 69; 103 ppm hydrogen sulfide gas

Primary: Nrf2 Activation in Nasal Epithelial Cells — 0; 0; 4; 4 participants

Primary: Small Bowel Water Content Measured by MRI — -5662; 3194; 10586 mL*min

Primary: Glycemic Response to the Diet — -103.44; -501.91 mg/dL/min

Primary: Change in Fruit, Vegetable Consumption as Measured by Food Frequency Questionnaire at 3 Months — 2.7272727; 2.9758065; 2.7330645; 0.4720000 number of servings per day

Primary: Peak Plasma Concentration of 14C-BaP Cmax — 3.69; 1.67; 0.68 fg [14C]-BaP/mL plasma

Primary: HEI-2015 Total and Component Scores — 61.6; 65.7; 2.1; 2.3 score on a scale — p=1.00

Primary: Change in Positive and Negative Syndrome Scale (PANSS) Score From the Start to the End of the Double-blind Treatment Phase — 81.0; 81.5; 81.7; 79.7 score on a scale